Stocks · News reference
Nebius Group NV (NASDAQ: NBIS) stock falls Friday as earnings reports from Amazon and Intel raises questions about cloud and AI infrastructure spending.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Wall Street veteran Steve Neamtz says AI capex winners will be identified by measurable returns and revenue growth as spending rises.
Amazon has secured a new $80 billion supplier financing credit facility to support its ongoing infrastructure investments in artificial intelligence.
Elon Musk warned that over 200 neoclouds (companies renting GPU computing power) face potential failure and consolidation as debt markets tighten access to capital. While hyperscalers like SpaceX, Alphabet, and Microsoft maintain investment-grade ratings and cheap capital access, smaller players like CoreWeave face rising bond yields and financing costs. Market consolidation could ultimately benefit stronger players and stabilize the AI infrastructure industry.
Amazon stock fell 1.41% after missing Q3 revenue and earnings expectations, with concerns over heavy AI capital expenditures ($220B planned for 2026) and negative free cash flow of $42.4B over the trailing 12 months. However, AWS grew 39% year-over-year, and the company's $114B in liquidity provides a cushion. The broader market declined with S&P 500 down 2.07% and Nasdaq down 2.86%, while retail competitors Walmart and Costco gained.
Axon Enterprise and DocuSign represent different investment profiles: Axon offers faster growth (33.5% revenue growth) in public safety technology with a premium valuation (49.8x forward P/E), while DocuSign provides steadier cash generation (8.2% revenue growth) at a more reasonable valuation (16.6x forward P/E). Despite Axon's impressive growth prospects, the article recommends DocuSign for 2026 due to its more attractive valuation and reasonable forward multiples.
Amazon disclosed that its pharmacy business saw a 60% year-over-year increase in customers, with three-hour prescription delivery now available in over 350 cities.